| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0e5ca7f8c702d2f64e033be4fdad8f0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4709 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 |
| filingDate |
2017-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52dbfe4ced6280befc73c8f90baa7c02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_347777d2b7ed4fb457cf5bdc7a4aeb28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8998d7dc0571da62678084ddbc4f1984
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12a013c7c29d837e4ad65d080ab2be43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f47e5558d4f999dfe7243ca57c78ec8d |
| publicationDate |
2019-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2019162738-A1 |
| titleOfInvention |
Salivary abeta42 levels as prognostic indicators for alzheimer's disease |
| abstract |
Methods and kits for accurate determination of salivary levels of Abeta42 are provided. A method of analysing a saliva sample includes the steps of obtaining the saliva sample from a subject; stabilizing the saliva sample; measuring the level of Abeta42 present in the stabilized saliva sample by contacting the stabilized saliva sample with an antibody capable of binding to Abeta42; comparing the determined level of the Abeta42 present in the stabilized saliva with that of a control level of Abeta42 derived from a saliva sample of an unaffected control group sample; and displaying the comparison of the determined level and the control level, wherein the determined level relative being greater than the control level is indicative of Alzheimer's disease in the subject or the subject being at risk of developing Alzheimer's disease. |
| priorityDate |
2016-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |